Agilent Technologies Inc at Goldman Sachs Global Healthcare Conference Transcript

Jun 15, 2022 / 05:00PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst

Okay. Great. Welcome, everybody. Good morning. I'm Matt Sykes, Life Science Tools and Diagnostics analyst at Goldman Sachs. I have the pleasure of welcoming Agilent this morning. Mike McMullen, Chief Executive Officer; and Bob McMahon, Chief Financial Officer. Mike, Bob, thanks for coming.

Michael R. McMullen - Agilent Technologies, Inc. - CEO, President & Director

Thanks for having us.

Robert W. McMahon - Agilent Technologies, Inc. - Senior VP & CFO

Our pleasure. Thanks for having us.

Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst

Great. I think, Mike, we could probably spend the next 20, 30 minutes on Philadelphia Eagles, but I don't think anyone wants to hear that.

Michael R. McMullen - Agilent Technologies, Inc. - CEO, President & Director

I got those in my Walkman song of Fly, Eagles

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot